Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors
- 1 February 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 102 (2S), S60-S65
- https://doi.org/10.1097/tp.0000000000002014
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Donor-Derived Tuberculosis (TB) Infection in Lung Transplant Despite Following Recommended AlgorithmAmerican Journal of Transplantation, 2013
- Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantationLiver Transplantation, 2013
- Travel Medicine and Transplant Tourism in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Mycobacterium tuberculosis Infections in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis InfectionThe New England Journal of Medicine, 2011
- Tuberculosis Among Participants in an Academic Global Health Medical Exchange ProgramJournal of General Internal Medicine, 2011
- Systematic Review and Meta‐Analysis of TST Conversion Risk in Deployed Military and Long‐Term Civilian TravelersJournal of Travel Medicine, 2010
- Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical MicrobiologyClinical Infectious Diseases, 2009
- Screening for Tuberculosis in the Study of the Living Renal Donor in a Developing CountryTransplantation, 2006
- Pharmacokinetic Interactions with RifampicinClinical Pharmacokinetics, 2003